Overexpression of the ERG oncogene in prostate cancer identifies candidates for PARP inhibitor-based radiosensitization
{{output}}
Radiotherapy (RT) is a central treatment for prostate cancer (PCa), acting by inducing DNA double-strand breaks (DSBs). Tumor ability to repair these breaks limits RT efficacy, making DSB repair inhibitors potential radiosensitizers. Therefore, tumor-specific ... ...
